|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,222.50 INR | +1.03% |
|
-2.80% | +9.22% |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 621B 6.43B 5.64B 5.23B 4.81B 9.06B 9.19B 62.34B 24.4B 304B 24.15B 23.63B 1,049B | P/E 2026 |
44.2x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 582B 6.03B 5.28B 4.9B 4.5B 8.49B 8.61B 58.4B 22.86B 285B 22.62B 22.14B 983B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.5x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.51% | ||
| 1 week | -3.31% | ||
| Current month | +0.31% | ||
| 1 month | +1.45% | ||
| 3 months | -5.31% | ||
| 6 months | +12.37% | ||
| Current year | +8.64% |
| 1 week | 2,166 |  | 2,287.9 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.50% | -3.31% | +3.38% | +180.49% | 6.43B | |
| -0.53% | -0.85% | +14.92% | +75.71% | 48.31B | |
| -0.96% | -1.41% | +58.78% | +106.03% | 35.33B | |
| -0.86% | -1.75% | -4.68% | +33.90% | 11.85B | |
| -0.89% | -3.22% | +16.09% | +81.93% | 11.64B | |
| -0.37% | -0.19% | +36.48% | +136.73% | 8.99B | |
| -0.75% | +1.66% | +46.85% | -7.74% | 6.93B | |
| -0.34% | -2.25% | +14.42% | +33.03% | 6.72B | |
| -2.47% | -10.97% | -31.86% | +6.76% | 5.66B | |
| -1.29% | -1.08% | +25.64% | +139.69% | 4.48B | |
| Average | -0.77% | -2.61% | +18.00% | +78.65% | 14.64B | |
| Weighted average by Cap. | -0.70% | -1.31% | +24.84% | +81.87% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.59B 1.39B 1.29B 1.19B 2.23B 2.27B 15.38B 6.02B 74.92B 5.96B 5.83B 259B | 167B 1.73B 1.51B 1.41B 1.29B 2.43B 2.47B 16.74B 6.55B 81.58B 6.49B 6.35B 282B |
| Net income | 20.53B 213M 186M 173M 159M 300M 304M 2.06B 807M 10.05B 799M 782M 34.71B | 23.28B 241M 211M 196M 180M 340M 345M 2.34B 915M 11.39B 906M 886M 39.36B |
| Net Debt | -39.29B -407M -357M -331M -304M -574M -582M -3.95B -1.54B -19.23B -1.53B -1.5B -66.42B | -37.12B -385M -337M -313M -288M -542M -550M -3.73B -1.46B -18.16B -1.44B -1.41B -62.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | ₹2,222.50 | +1.03% | 266,434 |
| 22/07/26 | ₹2,199.90 | -1.88% | 942,175 |
| 21/07/26 | ₹2,242.10 | +0.12% | 274,753 |
| 20/07/26 | ₹2,239.50 | +0.18% | 914,679 |
| 17/07/26 | ₹2,235.50 | -2.25% | 355,968 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
